Open AccessGranulocyte-colony stimulating factor therapy improves survival in patients with hepatitis B virus-associated acute-on-chronic liver failure
Author(s) -
Xiaojiang Duan,
Fangfang Liu,
Jingjing Tong,
Haozhen Yang,
Jing Chen,
Xiaoyan Liu,
Yuanli Mao,
Shaojie Xin,
Jinhua Hu
Publication year - 2013
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v19.i7.1104
Subject(s) - medicine , gastroenterology , granulocyte colony stimulating factor , white blood cell , liver function , hepatitis b , hepatitis b virus , liver disease , immunology , virus , chemotherapy
To evaluate the safety and efficacy of granulocyte-colony stimulating factor (G-CSF) therapy in patients with hepatitis B virus (HBV)-associated acute-on-chronic liver failure (ACLF).